Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jan 16, 2021; 9(2): 334-343
Published online Jan 16, 2021. doi: 10.12998/wjcc.v9.i2.334
Table 1 Clinical and laboratory characteristics of patients with ulcerative colitis and healthy controls
Control, n = 172
Ulcerative colitis, n = 172
P value
Male, n (%)96 (55.81%)91 (52.90%)0.588
Age (yr)47.50 (37.00-56.00)48.00 (35.00-57.00)0.545
WBC (× 109/L)5.37 (4.47-6.29)7.26 (5.85-9.23)< 0.001
HB (g/L)138.00 (125.00-152.50)131.00 (122.00-143.00)0.001
PLT (× 109/L)213.00 (179.50-251.00)245.00 (197.00-312.00)< 0.001
N (× 109/L)3.11 (2.55-3.86)5.48 (4.07-7.25)< 0.001
L (× 109/L)1.67 (1.35-2.08)1.25 (0.97-1.70)< 0.001
M (× 109/L)0.30 (0.24-0.37)0.33 (0.18-0.49)0.295
SII (× 109/L)384.86 (282.31-557.42)1063.23 (587.24-1787.87)< 0.001
NLR, %1.83 (1.45-2.47)4.31 (2.73-6.47)< 0.001
PLR, %127.49 (98.71-156.21)191.87 (130.97-263.89)< 0.001
HB: Hemoglobin; L: Lymphocytes; M: Monocytes; N: Neutrophils; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; PLT: Platelet; SII: Systemic immune-inflammation index; WBC: White blood cell.